Company intelligence / Profile preview
Arcturus Therapeutics
San Diego, California, United Statesarcturusrx.com ↗
- Ownership
- Public · ARCT
- Employees
- ~124
- Development stage
- Other
01
Overview
Arcturus has advanced a late-stage pipeline of mRNA-based medicines and vaccines. Its COVID‑19 vaccine Kostaive® received regulatory approval in Japan and the EU, marking the first commercial launch of a self-amplifying mRNA vaccine. The company’s rare disease programs—ARCT‑810 for OTCD and ARCT‑032 for cystic fibrosis—are both in Phase 2 clinical trials, with interim data expected in mid to late 2025. Early results show favorable safety profiles supporting continued development.[6][9]
- Therapeutic areas
- OncologyPulmonologyInfectious DiseasesMetabolic Disorders
- Modalities
- messenger RNA (mRNA)self-amplifying mRNA (sa-mRNA)small interfering RNA (siRNA)circular RNA (circRNA)antisense oligonucleotides (ASO)gene editing RNA/DNA therapeutics[7][10]
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
CSL Seqirus (global collaboration on innovative mRNA vaccines) [10]Achilles Therapeutics plc (personalized cancer vaccines) [5]
04
Financials
- Market cap
- $266M
- Total revenue
- $67.2M
- Enterprise value
- $99.5M
Beyond the preview
Go deeper on Arcturus Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arcturus Therapeutics.